Suchergebnisse - "Virus Diseases"

PubPharm (16.891)

111

Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults : A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral-Vectored Sudan Ebolavirus Vaccine in Healthy Adults

enthalten in: ClinicalTrials.gov | 2024

112

Ebola Virus Disease Sensitization : Community-Driven Efforts in Sierra Leone

enthalten in: Journal of community health | 2024

von Collier, K. | Klein, E. | Sevalie, S. | +11

113

VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents : VRC 705: A Phase 2/2B, Randomized Trial to Evaluate the Safety, Immunogenicity and Efficacy of a Zika Virus DNA Vaccine in Healthy Adults and Adolescents

enthalten in: ClinicalTrials.gov | 2024

114

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection : A Phase 1b, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Treatment With JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, HBeAg-negative Participants With Chronic Hepatitis B Virus Infection

enthalten in: ClinicalTrials.gov | 2024

115

WiseApp for Spanish Speakers Living With HIV : WiseApp for Spanish-Speaking Latino Persons Living With HIV (PLWH) in the United States (US) and the Dominican Republic (DR)

enthalten in: ClinicalTrials.gov | 2024

116

The Trend of C-Reactive Protein After Corticosteroid Therapy in COVID-19 Patients Admitted to IGIMS, Patna

enthalten in: Cureus | 2024

von Singh, N. | Kumar, R. | Kumar, S. | +3

117

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age : Randomized Phase I/II Study of the Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

enthalten in: ClinicalTrials.gov | 2024

118

Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells for Viral Infections After Stem Cell Transplant : A Randomized Trial of Scheduled Versus Treatment Administration of Donor-Derived Viral Specific T-cells (VSTs) for Control of Viral Infections After Allogeneic Stem Cell Transplant

enthalten in: ClinicalTrials.gov | 2024

119

The potential risk components and prevention measures of the Ebola virus disease outbreak in Liberia : An in-depth interview with the health workers and stakeholders

enthalten in: Belitung nursing journal | 2024

von Stephens, M. | Juniastuti | Sulistiawati | +1

120

Third Party Viral Specific T-cells (VSTs) : Third Party Viral Specific T-cells (VSTs) for Treatment of Viral Infections in Immunocompromised Patients

enthalten in: ClinicalTrials.gov | 2024